mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |